AdvanCell is a Biotech company based in Brisbane, Australia. It has raised $440M in total funding. Latest round: Series D.
AdvanCell is a Biotech company based in Brisbane, Australia. AdvanCell has raised $440M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in January 2026. The round record for AdvanCell runs through 2026; nothing later has been disclosed. Investors on record include Ally Bridge Group, Alpha Wave, Bain Capital Life Sciences, Fidelity Management & Research, T. Rowe Price, Qatar Investment Authority and 8 others. 14 distinct backers are named across the disclosed rounds.
Round data for AdvanCell is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Brisbane and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026